9-137236154-A-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001177316.2(SLC34A3):c.1538A>T(p.Glu513Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.857 in 1,609,720 control chromosomes in the GnomAD database, including 593,168 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001177316.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC34A3 | NM_001177316.2 | c.1538A>T | p.Glu513Val | missense_variant | 13/13 | ENST00000673835.1 | NP_001170787.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC34A3 | ENST00000673835.1 | c.1538A>T | p.Glu513Val | missense_variant | 13/13 | NM_001177316.2 | ENSP00000501114.1 | |||
SLC34A3 | ENST00000361134.2 | c.1538A>T | p.Glu513Val | missense_variant | 13/13 | 2 | ENSP00000355353.2 | |||
SLC34A3 | ENST00000538474.5 | c.1538A>T | p.Glu513Val | missense_variant | 13/13 | 5 | ENSP00000442397.1 |
Frequencies
GnomAD3 genomes AF: 0.889 AC: 135208AN: 152136Hom.: 60498 Cov.: 34
GnomAD3 exomes AF: 0.882 AC: 211353AN: 239692Hom.: 93815 AF XY: 0.880 AC XY: 115667AN XY: 131382
GnomAD4 exome AF: 0.853 AC: 1243773AN: 1457466Hom.: 532609 Cov.: 82 AF XY: 0.855 AC XY: 620212AN XY: 725086
GnomAD4 genome AF: 0.889 AC: 135328AN: 152254Hom.: 60559 Cov.: 34 AF XY: 0.887 AC XY: 65997AN XY: 74428
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 03, 2014 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 21, 2016 | p.Glu513Val in exon 13 of SLC34A3: This variant is not expected to have clinical significance because it has been identified in 99.94% (8411/8416) of East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitu te.org; dbSNP rs28542318). - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Autosomal recessive hypophosphatemic bone disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at